InvestorsHub Logo
Followers 58
Posts 3943
Boards Moderated 0
Alias Born 04/23/2013

Re: None

Saturday, 05/24/2014 9:35:00 AM

Saturday, May 24, 2014 9:35:00 AM

Post# of 425931
Forget the numbers, forget the TG numbers, forget the HDL, LDL, Apo-B, AA/EPA ratio and all the other Lipid numbers. But remember Inflammation! Reduce inflammation in your arteries, heart lining, brain, joints, pancreas, prostate, liver, bowels, colon, or _______, you name the organ! Everyone knows that Omega 3’s are anti-inflammatory. GSK knows this, PFE knows this and certainly AZN knows this. That’s why they are currently experimenting with various combinations of DHA and EPA in their new drug EPANOVA. What they are finding and what Amarin already knows and has 40 patents to protect is that the single OM3 (EPA) concentrated to at least 96% pure in 4g/day dosage is the most effective treatment for dyslipidemia. Furthermore, time will tell that this single drug will be shown to be effective in treating or preventing a host of inflammation related diseases and conditions such as CVD’s, Brain Injuries, crones disease, colitis, arthritis, prostate cancer just to name a few. Don’t let anyone tell you differently. The VASCEPA drug is wanted by the BP companies and they are doing everything in their power to stall Amarin’s FDA approval, but the science will eventually prevail.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News